Welcome to ATMP Sweden!
'ATMP Sweden' is the national network of Sweden's activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.
Who are we?
Join our experts in the science and technology for GMP compliant clinical translation of ATMP research.
Join our experts in the knowledge, processes and competencies for getting ATMPs to patients.
Work with us towards making ‘Sweden a world leader in advanced therapies by 2030’
Subscribe to our mailing list
Subscribe to receive our quarterly newsletter and updates on the next ATMP Sweden conference.
Follow us on LinkedIn!
Förberedelse för innovationsmöte 28:e Jan, 2021
News
Amniotics AB pioneer in-house GMP production
2021-01-15
Tips for setting up MPA approved GMP manufacture facilities within a small cell therapy company
Read moreATMP SWEDEN NEWSLETTER DECEMBER 2020
2020-12-16
Catch up on the latest including launch of the commercialisation resources developed by Swelife-ATMP!
Read more
Launch of the SDP3 report and resources!
2020-12-10
Find information and tools to assist in establishing your business model.
Read moreResources
Watch recordings from different projects within our National Networks.
Use this guide to navigate development of an ATMP through manufacture and Clinical Trial Application.
Find or advertise ATMP relevant job opportunities here!
What are ATMPs?
Events
Other collaborating national projects
VOG cell is responsible for ensuring Swedish GMP manfacturing facilities function at the highest level and are compliant with current regulations.
AdBIOPRO is developing Continuous Processing of emerging potent therapeutic products such as recombinant viral vector and cell Products.
Sweden are world leader in NK cell research and this group are world leaders in NK cell therapies for patients!
See all ATMP relevant organisations here